Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation J.S. Healey, R.D. Lopes, C.B. Granger, M. Alings, L. Rivard, W.F. McIntT h e n e w e ngl a nd j o u r na l o f m e dic i n e-Alings, dr. A.M.W.-ARTESiA-Arrhythmia
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trialAm Heart J-Abstract-Alings, dr. A.M.W.-ARTESiA-Arrhythmia